{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:37:25Z","timestamp":1776479845472,"version":"3.51.2"},"reference-count":31,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["COPD"],"DOI":"10.2147\/copd.s440895","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T10:55:35Z","timestamp":1704797735000},"page":"77-86","source":"Crossref","is-referenced-by-count":10,"title":["Real-World Effectiveness Study of Nirmatrelvir-Ritonavir or Molnupiravir in Hospitalized Unvaccinated Patients with Chronic Respiratory Diseases and Moderate COVID-19 at Presentation"],"prefix":"10.2147","volume":"Volume 19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-1637","authenticated-orcid":true,"given":"Wang Chun","family":"Kwok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Chi Leung","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Sau-Man","family":"Ip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8811-1308","authenticated-orcid":true,"given":"Pak Leung","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1015355","DOI":"10.3389\/fimmu.2022.1015355","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"eabq4064","DOI":"10.1126\/scitranslmed.abq4064","volume":"15","author":"Sasaki","year":"2022","journal-title":"Sci Trans Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"115503","DOI":"10.1016\/j.ejmech.2023.115503","volume":"257","author":"Yang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"102329","DOI":"10.1016\/j.dsx.2021.102329","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jinf.2023.02.012","volume":"86","author":"Evans","year":"2023","journal-title":"J Infect"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/v15030811","volume":"15","author":"Mutoh","year":"2023","journal-title":"Viruses"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0140-6736(22)01586-0","volume":"400","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/crj.13480","volume":"16","author":"Kwok","year":"2022","journal-title":"Clin Respir J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.2147\/COPD.S276692","volume":"15","author":"Gomez Antunez","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1753466621995043","DOI":"10.1177\/1753466621995043","volume":"15","author":"Choi","year":"2021","journal-title":"Ther Adv Respir Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"100900","DOI":"10.1016\/j.resmer.2022.100900","volume":"81","author":"Cilli","year":"2022","journal-title":"Respir Med Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/v15030610","volume":"15","author":"Kwok","year":"2023","journal-title":"Viruses"},{"key":"ref15","unstructured":"Foster City CBGS, Inc. Veklury. US FDA approved product information; 2020. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/214787Orig1s000lbl.pdf. Accessed January 4, 2023."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7326\/M22-3057","volume":"176","author":"Wan","year":"2023","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/S1473-3099(22)00507-2","volume":"22","author":"Wong","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"ref18","unstructured":"FDA. Fact Sheet for Healthcare Providers: Emergency Use Authorization for Paxlovid\u2122. FDA, editor. The United States Food and Drug Administration (FDA); 2022."},{"key":"ref19","unstructured":"FDA. Fact Sheet for Healthcare Providers: Emergency Use Authorization for Lagevrio\u2122 (Molnupiravir) Capsules. FDA, editor. The United States Food and Drug Administration (FDA); 2021."},{"key":"ref20","unstructured":"EMA. Summary of Product Characteristics - Nirmatrelvir-Ritonavir. EMA, editor. European Medicines Agency (EMA); 2022."},{"key":"ref21","unstructured":"EMA. Conditions of Use, Conditions for Distribution and Patients Targeted and Conditions for Safety Monitoring Addressed to Member States for Unauthorised Product Lagevrio (Molnupiravir) Available for Use. EMA, editor. European Medicines Agency (EMA); 2022."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e28889","DOI":"10.1002\/jmv.28889","volume":"95","author":"Amani","year":"2023","journal-title":"J Med Virol"},{"key":"ref23","unstructured":"HA CCIDER. Interim Recommendation on Clinical Management of Adult Cases with Coronavirus Disease 2019 (COVID-19). Hospital Authority Central Committee on Infectious Disease and Emergency Responses (HA CCIDER); 2023."},{"key":"ref24","unstructured":"NIH. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health (NIH); 2023."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.5421","volume":"31","author":"Ye","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/pds.5638","volume":"32","author":"Kwok","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/JAA.S405297","volume":"16","author":"Kwok","year":"2023","journal-title":"J Asthma Allergy"},{"key":"ref28","unstructured":"HA CCIDER. Interim Recommendation on Clinical Management of Adult Cases with Coronavirus Disease 2019 (COVID-19). Hospital Authority Central Committee on Infectious Disease and Emergency Responses (HA CCIDER); 2022."},{"key":"ref29","unstructured":"WHO. COVID-19 Clinical Management Living Guidance. Vol. 3. 3rd ed. WHO, editor. World Health Organization (WHO); 2021:116."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/v15041025","volume":"15","author":"Del Borgo","year":"2023","journal-title":"Viruses"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40121-022-00729-2","volume":"12","author":"Tiseo","year":"2023","journal-title":"Infect Dis Ther"}],"container-title":["International Journal of Chronic Obstructive Pulmonary Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=95876","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=95876","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T10:55:40Z","timestamp":1704797740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/real-world-effectiveness-study-of-nirmatrelvir-ritonavir-or-molnupirav-peer-reviewed-fulltext-article-COPD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2147\/copd.s440895","relation":{},"ISSN":["1178-2005"],"issn-type":[{"value":"1178-2005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}